NEU neuren pharmaceuticals limited

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-11

  1. 2,981 Posts.
    lightbulb Created with Sketch. 643
    Long-termers (such as myself) would know that there has been speculation at various times over the years, that NEU would be taken-over.

    I'd argued against that and statements from the company subsequently ruled that out until the phase 3 results (at the earliest).

    If trofinetide is approved, it would seem to me that it is almost certain that Acadia would make us an offer.

    There has been chatter also that Baker Bros might be positioning Acadia for a sale. Approval of trofinetide would help if that was the case.

    Maybe the SP action over the next 4 months might give us a hint as to either of those two possibilities playing out?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.24
Change
0.390(3.04%)
Mkt cap ! $1.652B
Open High Low Value Volume
$13.15 $13.37 $12.92 $4.253M 324.2K

Buyers (Bids)

No. Vol. Price($)
1 2 $13.24
 

Sellers (Offers)

Price($) Vol. No.
$13.25 230 6
View Market Depth
Last trade - 12.16pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.